Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05462236 |
| Title | MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AUM Biosciences Pte Ltd |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Chris O'Brien Lifehouse | RECRUITING | Camperdown | New South Wales | 2050 | Australia | Details |
| Prince of Wales Hospital | RECRUITING | Wollongong | New South Wales | 2500 | Australia | Details |
| Pindara Private Hospital, Gold Coast Cancer Care | RECRUITING | Benowa | Queensland | 4217 | Australia | Details |
| Cabrini Hospital | RECRUITING | Malvern | Victoria | 3144 | Australia | Details |
| Ballarat Oncology and Haematology | RECRUITING | Wendouree | Victoria | 3355 | Australia | Details |